Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYT005-AllQbG10 in House Dust Mite Allergy
NCT00574704Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Start
- Sep 2006
- Primary completion
- Mar 2008
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 2, randomised, double-blind trial of CYT005-AllQbG10 in perennial allergic rhinoconjunctivitis and house dust mite allergy, sponsored by Cytos Biotechnology AG. Started Sep 2006; status: completed.
02
Drugs
CYT005-AllQbG10
03
Conditions
perennial allergic rhinoconjunctivitishouse dust mite allergy
Beyond the preview
Go deeper on NCT00574704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574704.